IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q3 2018 Holdings

Filed 2018-11-13 | 10 holdings | $7.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Adaptimmune Therapeutics PLC(ADAPY)SPONDS ADR00653A107$6.8M500,00096.3%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$90.2K1,464,7491.3%
Aimmune Therapeutics, Inc.(AIMT)COM00900T107$90.0K3,300,7971.3%
Alder BioPharmaceuticals, Inc.(ALDR1EUR)COM014339105$26.4K1,586,2200.4%
Insmed Incorporated(INSM)COM457669307$19.6K967,6360.3%
Epizyme, Inc.(EPZMEUR)COM29428V104$15.2K1,432,3640.2%
Acceleron Pharma Inc.(XLRN)COM00434H108$12.6K220,2680.2%
Denali Therapeutics Inc.(DNLI)COM24823R105$5.4K250,0000.1%
BioDelivery Sciences International, Inc.(BDSIUSD)COM09060J106$2.7K949,2330.0%
Sangamo Therapeutics, Inc.(SGMO)COM800677106$1.4K80,5000.0%